Additionally, Crispr Therapeutics AG plans to engage with regulators regarding B-cell malignancies and expand trials to include conditions like systemic sclerosis and inflammatory myositis ...
Kennedy Jr., President Trump’s nominee to lead the health department, show that he plans to divest stock holdings, including stakes in CRISPR Therapeutics (CRSP) and privately-held Dragonfly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback